Insmed Incorporated $INSM rose 31% today following the release of its Q2 earnings report. The company reported total revenue of $425.5 million in the Q2, representing a 296% increase YoY.
• EPS:$-0.06 Est:$0.75
• The respiratory medication BRINSUPRI generated $309.2 million in revenue during the quarter, representing a 49% increase compared to the previous quarter. Approximately 7,000 new patients were started on the medication during the quarter.
• The company's record revenue of $309.2 million from its BRINSUPRI drug reduced the net loss from $321.69 million (Q2 2025) to just $13.24 million.

【$SOL Signal】Bearish momentum continues: 4H MACD expansion + order-book selling pressure
$SOL 1H MACD green histogram contracted to -0.0816, while the 4H green histogram expanded to -0.0623, with no sign of bearish momentum exhaustion. RSI 1H is 39.43, approaching oversold territory but without a reversal. Order-book depth imbalance is -5.13%, Bid/Ask is 0.90, and selling pressure is clearly dominant. The funding rate is -0.0101%, with bears holding a slight edge but not at an extreme. OI is stable, with no signs of a short squeeze for now. The current price of 73.19 is below the 1H Bollinger

This week’s hidden crypto gems, don’t miss the next moonshot💥
$SHIB
$PEPE
$BabyDoge
$WKC
$TROLL
$FLOKI

#KOSPIExtendsLossesTo3%
South Korean Stocks Under Pressure: Chip Selloff, Forced Deleveraging, and Rising Volatility Shake the KOSPI
South Korea's equity market remained under heavy pressure as the KOSPI extended its decline, with semiconductor giants leading another broad-based selloff. What initially appeared to be a reaction to weaker-than-expected guidance from the global memory industry has evolved into a much larger story driven by leverage, forced liquidations, and deteriorating investor sentiment.
The sharp decline in SK Hynix and Samsung Electronics once again highlighted how heavily

https://gate.onelink.me/Hls0/prediction?page=detail&event_ticker=481717&source=cex
Fed's Direction Changes: Markets Seek New Equilibrium
Markets, which had long been trading on the expectation of interest rate cuts, have seen a complete reversal of course. Following recent hawkish messages from Fed officials and a Financial Times report on Chairman Kevin Warsh, the possibility of a rate hike at the September meeting has become central to the agenda.
Hawk Wing Strengthens
While interest rates remained unchanged at the July FOMC meeting, the split in the vote was noteworthy. Three regional presi

I got back up again. When the time came, I woke up on my own between 4 and 6 a.m. and entered a BTC long at 64,434.2!
I had a great time having dinner with my students last night. I drank too much, and they took me back to the office. I took a look at the trend and thought it was going to fall, so I entered a short! I didn't even take a screenshot; I told them about it, so they know! I went short and then fell asleep, but I had already trained myself to have muscle memory—I had to set a stop-loss, and this time I set a take-profit. Then I woke up after 1 a.m. and saw that the take-profit had b

I meant to go long but clicked the wrong button and took a random loss.

It's a "double bottom" until it breaks.. then its time for pain

【$HFT Signal】Long | 1H breakout + funding rate anomaly
$HFT After breaking above the previous high, $HFT
1H pulled back. The buy ratio was 0.52, while the funding rate surged to 2%, indicating growing divergence between longs and shorts. The 4H MACD bullish momentum is expanding, while the 1H histogram is contracting, showing that upward momentum is fading. Order book depth imbalance stands at -16.3%, and the 4H RSI has reached 92.9, an extremely overbought zone, but OI remains stable and the price is holding firm. The short-term short-squeeze structure remains intact, so the risk-reward ratio

European regulators have flagged a genuine spike in impersonation scams tied directly to the fallout from MiCA's licensing deadline, and the mechanism behind it is fairly straightforward once you understand what actually changed on July 1.
MiCA's transitional period, which had allowed crypto firms to keep operating under national law while their EU-wide authorization was still pending, ended completely on that date. Any provider without a full MiCA license became legally required to stop onboarding new clients, cease marketing, and wind down EU operations, instructing existing customers to wit

🪙 $CRV Review/Analysis:
↗️ The price of CRV has held the key $0.20 level. This gives it the potential to begin an upward move following a local correction. The main target for price growth is the liquidity at previous highs above the $0.2280 level.

US spot Bitcoin ETFs pulled in $244.4 million in net inflows on August 5, capping three straight sessions of positive flows worth $626 million combined to open the month, and marking one of the strongest short stretches for these products in weeks.
BlackRock's IBIT once again did the heavy lifting, absorbing $196.8 million of that day's total, with ARKB adding $37.6 million, FBTC $11.3 million, BITB $10.6 million, and Morgan Stanley's MSBT $2.8 million. VanEck's HODL was the lone outlier, posting a $14.7 million outflow the same day, a reminder that even during a broadly positive stretch, flow

The chip sector’s “Battle Royale”! Micron is surging against the trend—is hard tech showing no sportsmanship? 🤯
Folks, today’s market is truly a case of “two worlds of ice and fire”! SanDisk, Western Digital, and SK hynix all plunged, with declines heading straight into the double digits—it’s enough to make your heart race. 😱
Yet amid this sea of losses, Micron Technology (MU) actually held its ground, slipping just 1.31%, while A-share counterpart Xianke Electronics surged 11% against the trend! This script is all too familiar—whenever panic selling hits the sector, it instead becomes a gre

This is what everyone is waiting for in Bitcoin.

$SOL , $BTC and $ETH have gone sideways for 6 months… but there have been some INSANE opportunities onchain. This is your daily reminder to lock in

【$ZBT Signal】1H breakout, bullish momentum continues
$ZBT RSI 85.73, broke above the 1H previous high of 0.1663, while the 4H Bollinger upper band at 0.1515 has been left behind. The bid/ask depth ratio is 1.73, with a depth imbalance of 26.61% and aggressive buying prevailing. The 4H MACD histogram has expanded consecutively, and bullish momentum is still being released. The funding rate of 0.005% is low, and short-squeeze potential has not been priced in. The current price of 0.1739 is close to the recommended entry zone—strike directly.
🎯 Direction: Long
⚡ Entry/limit order: 0.1734182 -

$TTD
This has to be one of the ugliest stock charts in history.

$RATS /USDT Perp – "Breakdown – Short Continuation"
Trading Plan Short $RATS
Entry: 0.0000455 – 0.0000460
SL: 0.0000470
TP1: 0.0000443
TP2: 0.0000420
RATS is down -14.93% with price at 0.00004530, below MA5 (0.00004577), MA10 (0.00004582), and MA30 (0.00004565) – bearish. 24h high at 0.00005661 with massive rejection. A break below 0.0000443 could accelerate toward 0.0000420. SL above 24h high at 0.0000470.
#MoonshotAIPreIPOsOpen